Mayumi advises a wide range of clients, from start-ups to multinational corporations and sovereign wealth funds on a range of corporate and commercial issues, with a particular focus on mergers and acquisitions, fund raising, equity capital markets, and employment law.
Mayumi's practice has an international outlook and she regularly works on cross-border matters. She is experienced in drafting, reviewing and negotiating a wide range of contracts and agreements throughout an M&A or fund-raising transaction. She is also familiar with equity capital markets, allowing her to provide strategic advice to businesses.
Mayumi also provides employment law advice to clients, and she has experience advising on the whole life cycle of an employment relationship, from hiring, managing the employment, to termination and retrenchment exercises. Her pragmatic and commercial approach to providing legal advice ensures that her clients receive accurate and reliable advice and that their best interests are always protected.
Senior Practice Development Lawyer
Tadeusz is responsible for a range of practice development activities within our Competition, EU & Trade team, supporting the team’s EU and UK competition law work. This includes delivering training, monitoring legal developments, sharing knowledge, developing best practices and resources, and facilitating innovation.
Tom specialises in obtaining authorisation for major infrastructure schemes with a particular emphasis in the energy and transport sectors.
Theresa is part of the German Intellectual Property team with focus on the Life Science sector as well as other high-tech industries. She advises national and international clients on all aspects of Intellectual Property and Unfair Competition Law including the draft and negotiation of licence agreements.
Tamsin is a Senior Associate in Pinsent Masons’ European IP practice, specialising in contentious patent issues. She advises a diverse portfolio of clients on patent matters related to technologies in a variety of industries including pharmaceuticals (small molecules and biosimilars) and medical devices.